As of Dec 02
| +0.19 / +3.72%|
The 4 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 4.00. The median estimate represents a +126.42% increase from the last price of 5.30.
The current consensus among 4 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.